LINDA GRAIS, M.D. - Corporate Board Profile

Oruka Therapeutics, Inc.

Filing Date	Source Excerpt
2009-04-30	Linda Grais, M.D. Dr. Grais has served as a member of the Company 2 Board of Directors since our merger with ARCA Colorado. Before the merger, Dr. Grais had served as a director of ARCA Colorado since May 2007. Dr. Grais is currently a partner at InterWest, where she has been since May 2005.
2010-04-07	Dr. Grais, age 53, has served as a member of the Company 27s Board of Directors since the merger with Nuvelo in January 2009. ... Dr. Grais is an appropriate nominee to the Company 27s Board of Directors because of her diverse training and experience as both a medical doctor and a lawyer, her experience as a founder and senior executive of a pharmaceutical company, and her experience as an investor in new life sciences companies. She has also has extensive experience with and knowledge of the Company 27s business from her service on the Board of ARCA Colorado since 2007, and her service as a Board and Committee member for the Company since January 2009.
2011-03-30	Dr. Grais, age 54, has served as a member of the Company 27s Board of Directors since the merger with Nuvelo in January 2009. ... The Board has also appointed Dr. Linda Grais as Lead Independent Director. ... The following table shows for the fiscal year ended December 31, 2010 certain information with respect to the compensation of all non-employee directors of the Company: ... Linda Grais, M.D. 40,000 6,435 46,435.
2012-04-05	Dr. Grais, age 55, has served as a member of the Companys Board of Directors since the merger with Nuvelo in January 2009. ... Dr. Grais also has extensive experience with and knowledge of the Companys business from her service on the Board of ARCA Colorado since 2007, and her service as a Board and Committee member for the Company since January 2009. ... The Audit Committee is composed of three directors: Dr. Zabriskie (chair), Dr. Grais, and Dr. Sobel. ... Dr. Grais was elected to serve as Compensation Committee Chairperson effective March 29, 2011. ... Director Compensation for fiscal 2011 shows Linda Grais, M.D. with total compensation of $60,000.
2013-02-01	Linda Grais, M.D. is listed as a director with beneficial ownership of 18,000 shares. No specific age, committees, or compensation details are provided.
2013-08-01	Dr. Grais, age 57, has served as a member of the Company 27s Board of Directors since the merger with Nuvelo in January 2009. ... Dr. Grais is an appropriate nominee to the Company 27s Board of Directors because of her diverse training and experience as both a medical doctor and a lawyer, her experience as a founder and senior executive of a pharmaceutical company, and her experience as an investor in new life sciences companies. She also had extensive experience with and knowledge of the Company 27s business from her service on the Board of ARCA Colorado since 2007, and her service as a Board and Committee member for the Company since January 2009. ... The Board has a Lead Independent Director, Dr. Linda Grais, who performs many of the duties of the Chairman when such position has not been appointed. ... The Audit Committee is currently composed of two directors: Dr. Zabriskie (chair) and Dr. Grais, as a result of the death of the third member in May, 2013. ... The Compensation Committee is currently composed of two directors: Dr. Linda Grais (chair) and Dr. Raymond Woosley. ... The Nominating and Corporate Governance Committee is currently composed of two directors, Dr. Grais and Dr. Woosley. ... The following table shows for the fiscal year ended December 31, 2012 certain information with respect to the compensation of all non-employee directors of the Company: ... Linda Grais, M.D. Fees Earned or Paid in Cash ($) 30,000, Option Awards ($) 5,457, Total ($) 35,457.
2014-04-15	Dr. Grais, age 57, has served as a member of the Company 27s Board of Directors since the merger with Nuvelo in January 2009. ... The Lead Independent Director position was created for those situations where the Chairman is not independent to serve as an independent balance to the Chairman and as the principal liaison between the Chairman and the independent directors. The Lead Independent Director, Dr. Grais, has performed many of the duties of the Chair during the period that the Chairmanship has been vacant. ... The Compensation Committee is currently composed of three directors: Mr. Robert Conway, Dr. Linda Grais (chair) and Dr. Raymond Woosley. ... The Nominating and Corporate Governance Committee is currently composed of three directors, Dr. Grais, Mr. Mitchell and Dr. Woosley. ... On February 11, 2014, Ms. Grais resigned from the Audit Committee upon Mr. Mitchell 27s appointment. ... The following table shows for the fiscal year ended December 31, 2013 certain information with respect to the compensation of all non-employee directors of the Company: ... Linda Grais ... Total($) 40,760.
2015-04-14	Dr. Grais, age 58, has served as a member of the Company’s Board of Directors since the merger with Nuvelo in January 2009. Before the merger, Dr. Grais had served as a director of ARCA Colorado since May 2007. Dr. Grais has been a director of Ocera Therapeutics, Inc., a public biopharmaceutical company, since January 2008 and became President and Chief Executive Officer of Ocera in June 2012. Dr. Grais served as a Managing Member at InterWest Partners, a venture capital firm from May 2005 until February 2011. From July 1998 to July 2003, Dr. Grais was a founder and executive vice president of SGX Pharmaceuticals Inc., a drug discovery company. Prior to that, she was a corporate attorney at Wilson Sonsini Goodrich & Rosati, where she practiced in such areas as venture financings, public offerings and strategic partnerships. Before practicing law, Dr. Grais worked as an assistant clinical professor of Internal Medicine and Critical Care at the University of California, San Francisco. Dr. Grais received a B.A. from Yale University, magna cum laude, and Phi Beta Kappa, an M.D. from Yale Medical School and a J.D. from Stanford Law School. Dr. Grais is an appropriate member of the Company’s Board of Directors because of her diverse training and experience as both a medical doctor and a lawyer, her experience as a founder and senior executive of a pharmaceutical company, and her experience as an investor in new life sciences companies. She also has extensive experience with and knowledge of the Company’s business from her service on the Board of ARCA Colorado since 2007, and her service as a Board and Committee member for the Company since January 2009. Director Compensation for fiscal 2014: $63,054.
2016-04-27	Dr. Grais, age 59, has served as a member of the Board of Directors since May 2007. ... Dr. Grais is an appropriate nominee to the Board of Directors because of her diverse training and experience as both a medical doctor and a lawyer, her experience as a founder and senior executive of a pharmaceutical company, and her experience as an investor in new life sciences companies. ... The Compensation Committee is currently composed of three directors: Mr. Robert Conway, Dr. Linda Grais (chair) and Dr. Raymond Woosley. ... The Nominating and Corporate Governance Committee is currently composed of three directors, Dr. Grais, Mr. Mitchell and Dr. Woosley (chair). ... Director Compensation for fiscal 2015: Linda Grais, M.D. Fees Earned or Paid in Cash ($) 45,000, Option Awards ($) 3,645, Total ($) 48,645.
2017-04-21	Dr. Grais, age 60, has served as a member of the Board of Directors since May 2007. ... In the fiscal year ended December 31, 2016, the Audit Committee was composed of three directors: ... Dr. Grais was appointed as a member of, the Audit Committee. ... The Compensation Committee is currently composed of three directors: ... Dr. Grais (chair) ... Director Compensation for Dr. Grais for fiscal 2016 was $67,479.
2018-04-18	Dr. Grais, age 61, has served as a member of the Board of Directors since May 2007. Dr. Grais has been a director of Ocera Therapeutics, Inc., a public biopharmaceutical company, since January 2008 and became President and Chief Executive Officer of Ocera in June 2012. Dr. Grais served as a Managing Member at InterWest Partners, a venture capital firm from May 2005 until February 2011. From July 1998 to July 2003, Dr. Grais was a founder and executive vice president of SGX Pharmaceuticals Inc., a drug discovery company. Prior to that, she was a corporate attorney at Wilson Sonsini Goodrich & Rosati, where she practiced in such areas as venture financings, public offerings and strategic partnerships. Before practicing law, Dr. Grais worked as an assistant clinical professor of Internal Medicine and Critical Care at the University of California, San Francisco. Dr. Grais received a B.A. from Yale University, magna cum laude, and Phi Beta Kappa, an M.D. from Yale Medical School and a J.D. from Stanford Law School. Since September 2015, Dr. Grais has served on the board of PRA Health Sciences, a public contract research organization. We believe Dr. Grais is an appropriate member of the Board of Directors because of her diverse training and experience as both a medical doctor and a lawyer, her experience as a founder and senior executive of a pharmaceutical company, and her experience as an investor in new life sciences companies. She also has extensive experience with and knowledge of the Company’s business from her service on the Board of Directors of the Company since 2007. Director Compensation For fiscal year ended December 31, 2017, Dr. Grais received $52,500 in fees earned or paid in cash and $12,220 in option awards, totaling $64,720.
2018-09-20	The following table sets forth certain information regarding the ownership of the Companys Common Stock as of the August 31, 2018, by: (i) each director and nominee for director, (ii) each of our named executive officers, (iii) all executive officers and directors of the Company as a group, and (iv) all those known by the Company to be beneficial owners of more than five percent of its Common Stock.
2019-10-25	Dr. Grais, age 63, has served as a member of the Board of Directors since May 2007. ... The Audit Committee is composed of three directors: Mr. Conway (chair), Mr. Mitchell and Dr. Grais. ... The Compensation Committee is currently composed of three directors: Mr. Conway, Dr. Grais (chair) and Dr. Woosley. ... Director Compensation for Fiscal 2018 ... Linda Grais, M.D. ... $57,140.
2020-10-28	Linda Grais, M.D. Dr. Grais, age 64, has served as a member of the Board of Directors since May 2007. ... The Compensation Committee is currently composed of three directors: Mr. Conway, Dr. Grais (chair) and Dr. Woosley. ... Director Compensation for Fiscal 2019 shows Dr. Grais received $52,500 in cash fees.
2021-04-21	Dr. Grais, age 64, has served as a member of the Board of Directors since May 2007. ... We believe Dr. Grais is an appropriate member of the Board of Directors because of her diverse training and experience as both a medical doctor and a lawyer, her experience as a founder and senior executive of a pharmaceutical company, and her experience as an investor in new life sciences companies. ... The Audit Committee was composed of three directors: Mr. Conway (chair), Mr. Mitchell and Dr. Grais. ... The Compensation Committee of the Board of Directors, or the Compensation Committee, is currently composed of three directors: Mr. Conway, Dr. Grais (chair) and Dr. Woosley. ... Director Compensation for Fiscal 2020 ... Linda Grais, M.D. ... $52,500 ...
2022-11-03	Dr. Grais, age 65, has served as a member of the Board of Directors since May 2007. ... Dr. Grais is an appropriate member of the Board of Directors because of her diverse training and experience as both a medical doctor and a lawyer, her experience as a founder and senior executive of a pharmaceutical company, and her experience as an investor in new life sciences companies. ... Dr. Grais also joined the board of Corvus Pharmaceuticals., a publicly traded pharmaceutical company, in January 2019. ... The Audit Committee was composed of three directors: Mr. Conway (chair), Mr. Mitchell and Dr. Grais. ... The Compensation Committee of the Board of Directors, or the Compensation Committee, is currently composed of three directors: Mr. Conway, Dr. Grais (chair) and Dr. Woosley. ... In 2022, the Board of Directors established a Special Committee ... The Special Committee includes ... Linda Grais, M.D. ... Director Compensation for Fiscal 2021 ... Linda Grais, M.D. ... Fees Earned or Paid in Cash ($) 56,250 ... Option Awards ($) 39,187 ... Total ($) 95,437.
2023-12-19	Dr. Grais, age 67, has served as a member of the Board of Directors since May 2007. ... She serves on the Audit Committee and is Chair of the Compensation Committee. Director compensation for 2022 was $68,836.